Table 1.
Name | Sequence |
---|---|
2AY-S | (5'-GGAATTCGGGAAATTTGGACAG-3') |
2AY-AS | (5'-CCGCTCGAGTTACTGCTCCATGGCTTC-3') |
2AY-21S | (5'-GGAATTCCATCTTGCTACTCATAA-3') |
2AY-41S | (5'-GGAATTCCTCGTATCATCTACCAC-3') |
2AY-61S | (5'-GGAATTCGGAGTGTATTATTGTAA-3') |
2AY-90AS | (5'-TTATTAATAATACTCGCTGGCCTC-3') |
2AY-110AS | (5'-TTATTAGCAATCCCCTGGTTCCGA-3') |
2AY-130AS | (5'-TTATTAGCAATCCCCTGGTTCCGA-3') |
VP1/2A-S | (5'-CCATCGATATGATGGGTACGTTC-3') |
2A-S10 | (5'-GGAATTCATGGGGAAATTTGGACAGCAG-3') |
2A-AS2 | (5'-GCTCTAGACTACTGCTCCATGGCTTCATCATC-3') |
2A-AS3 | (5'-GCTCTAGACTGCTCCATGGCTTCATCATC-3') |
C110A-S | (5'-CCAGGGGATGCCGGTGGCATTCTTAGATGC-3') |
C110A-AS | (5'-AATGCCACCGGCATCCCCTGGTTCCGAATG-3') |
L30/43-S | (5'-CATAATGACTGGGCAAACTCATCTACCACTGCTCAA-3') |
L30/43-AS | (5'-TTGAGCAGTGGTAGATGAGTTTGCCCAGTCATTATG-3') |
2AY-AS101 | (5'-CCGCTCGAGTTACTGATCATCCAACCACAGAAG-3') |
2A-AS301 | (5'-GCTCTAGACTGATCATCCAACCACAGAAG-3') |
CoxB2AY-S | (5'-GGAATTCATGGGACAACAATCAGGGGC-3') |
CoxB2AY-AS | (5'-TTATTACTGTTCCATTGCATCATC-3') |
CoxB2AY-61S | (5'-GGAATTCTTTTGTGCGTCCAAAAAC-3') |
CoxB2AY-127AS | (5'-TTATTAGCCTTCACCCCCCATGGT-3') |
PCBP2-S | (5'-CTCTCACCATCCGGCTACTTAT-3') |
PCBP2-AS | (5'-GCTGCTTATGTCCTCTTCCAGT-3') |
PTBP1-S | (5'-CTACATCCAGTTCTCCAACCAC-3') |
PTBP1-AS | (5'-GCTGCTTATGTCCTCTTCCAGT-3') |
RTN3-S | (5'-ACTCTGTCCTCAGAAGCTTTCC-3') |
RTN3-AS | (5'-CTCATAGACAATCGGGACACTG-3') |
GBF1-S | (5'-CCCACTATTGCTGCTCTCTCTT-3') |
GBF1-AS | (5'-CTGGGCAGGTTCTCAATAGACT-3') |
CD55-S | (5'-CCGTCTTCTATCTGGTTCTCGT-3') |
CD55-AS | (5'-GTTACTAGCGTCCCAAGCAAAC-3') |
SAM68-S | (5'-CGAAGGCTATTACAGCCAGAGT-3') |
SAM68-AS | (5'-CATATGGGTGCTCTCTGTATGC-3') |
Note: Nucleotides for restriction enzyme cutting sites are italicized. Nucleotides for point mutations are bold and italicized. Nucleotides for start and stop codons are marked with bold letters. Primers for the detection of cellular genes were used in real-time RT-PCR.